Manager TitleAgeSince
President 55 -
Corporate Secretary - -
Treasurer 56 -
Director TitleAgeSince
Director/Board Member 56 05/07/2023
Director/Board Member - 05/09/2023
Director/Board Member 55 -
Date Insider Type Main position Quantity % Market Cap.
05/09/23Issuer sale

Director

18,379 0.2333%
05/09/23Issuer sale

Director

19,909 0.2527%
05/09/23Issuer sale

General Counsel

18,000 0.2285%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 17.8M
+4.33%+8.34%-15.45%+11.20% 121B
-0.65%+1.20%+3.41%-8.11% 12.85B
-0.24%+8.35%+40.65%+106.63% 8.37B
-3.88%-6.41%-50.89%-72.88% 3.95B
-0.38%-0.97%+16.76%+37.20% 2.53B
-9.06%+10.10%+218.77%+159.71% 1.7B
-8.75%-13.25%-27.64%-24.60% 1.68B
-2.80%-3.48%-2.92%-23.20% 1.57B
Average -2.33%-0.90%+22.84%+23.24% 19.23B
Weighted average by Cap. +3.05%+2.40%-8.62%+13.95%
Logo Conformis, Inc.
Conformis, Inc. is a medical technology company. The Company is engaged in the development, manufacturing, and sales of patient-specific products and instrumentation that are individually sized and shaped to fit each patient's various knee and hip anatomy. The Company offers knee replacement products and knee replacement products. The Company's product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant Platinum Services Program, as well as data-informed, standardized solutions that combine many benefits of personalization with an off-the-shelf system. Its sterile, just-in-time, Surgery-in-a-Box delivery system is available with all of its implants and personalized, single-use instruments. The Company owns or in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.
Employees
295
  1. Stock Market
  2. Stocks
  3. CFMS Stock